MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Assessment, identification and classification of movement disorders in 22q11.2 deletion syndrome

    W. Fung, A. Cunningham, T. Massey, J. Hall, M. Owen, M. Van-Den-Bree, K. Peall (Newport, United Kingdom)

    Objective: To assess the nature and frequency of movement disorders in children with molecularly confirmed 22q11.2 Deletion Syndrome. Background: 22q11.2 Deletion Syndrome (22q11.2DS) is a…
  • 2019 International Congress

    The Role of Environmental Toxins (Rotenone) in Parkinson’s Disease

    Z. Akbarkhodjaeva, DJ. Tursunov (Tashkent, Uzbekistan)

    Objective: Learn the role of environmental toxins - rotenone in development of Parkinson's disease Background: Rotenone is a powerful pesticide. It is also a lipophilic…
  • 2019 International Congress

    The Relationship of Neuropsychiatric Symptoms and Cognitive Impairment in Parkinson’s Disease

    B. Bernard, G. Stebbins, A. Negron, D. Merkitch, J. Goldman (Chicago, IL, USA)

    Objective: To assess the relationship between individual items from the Neuropsychiatric Inventory and five cognitive domains in patients with Parkinson's disease (PD) and normal cognitive…
  • 2019 International Congress

    The Influence of Sociodemographic Factors on Post-DBS Impulse Control Symptom Severity in Parkinson’s Disease

    H. Combs, A. Strutt, J. Jimenez-Shahed, N. Niemann, A. Viswanathan, M. York (Houston, TX, USA)

    Objective: To develop a model to predict changes in impulse control symptom severity (ICSS) following deep brain stimulation (DBS) in patients with Parkinson’s disease (PD).…
  • 2019 International Congress

    Relationships of gender, care models, and neuropsychiatric symptoms in Parkinson’s disease

    J. Goldman, S. Wu, C. Martinez-Rubio, V. Todaro (New York, NY, USA)

    Objective: To examine relationships among gender, care models, and presence and management of neuropsychiatric symptoms of Parkinson’s disease (PD). Background: Neuropsychiatric symptoms such as depression…
  • 2019 International Congress

    Cognitive impairment in patients with Parkinson’s Disease

    E. Kolupaeva, I. Zhukova, N. Zhukova, M. Nikitina, O. Izhboldina, I. Mironova, Z. Kislukhina (Tomsk, Russian Federation)

    Objective: The objective is to study the relation between cognitive impairment with the form and stage of PD. Background: Currently, there is a tendency of…
  • 2019 International Congress

    The radiofrequency (RF)-induced heating profile of an externalized, directional DBS lead using functional imaging sequences in an Intraoperative Magnetic Resonance Imaging Suite (IMRIS)

    P. Bhattacharyya, S. Jones, M. Lowe, M. Deblock, A. Machado, K. Baker (Cleveland, OH, USA)

    Objective: To characterize the RF-induced heating profile of the St. Jude Infinity lead within an IMRIS using a configuration that emulates intraoperative functional MRI during…
  • 2019 International Congress

    Classify Parkinson’s Disease with Mild Cognitive Impairment: Machine Learning Approach

    SS. Cho, C. Li, Y. Koshimori, J. Kim, L. Christopher, M. Dı´ez-Cirarda, M. Valli, A. Mihaescu, S. Houle, A. Strafella (Toronto, ON, Canada)

    Objective: To determine how multimodal neuroimaging data can contribute to the classification of Parkinson’s disease (PD) patients with mild cognitive impairment (MCI) from PD without…
  • 2019 International Congress

    Usefulness of Cardiac MIBG Scintigraphy, DAT scan and midbrain/pontine ratio to differentiate Parkinson disease from atypical parkinsonian syndrome

    H. Fujita, K. Suzuki, Y. Watanabe, M. Hamaguchi, K. Hirata (Mibu, Japan)

    Objective: The purpose of this study was to evaluate the usefulness of cardiac 123I-metaiodobenzylguanidine (MIBG) uptake, Dopamine transporter (DAT) scan and midbrain/pontine ratio (M/P ratio)…
  • 2019 International Congress

    Opposing effects of levodopa on basal ganglia activity in Parkinson’s disease during motion and rest

    R. Jech, S. Holiga, F. Růžička, H. Möller, J. Roth, M. Schroeter, E. Růžička, K. Mueller (Prague, Czech Republic)

    Objective: To explore the pattern of activation within the motor network during the movement and resting phases of the tapping task in Parkinson’s disease (PD)…
  • « Previous Page
  • 1
  • …
  • 187
  • 188
  • 189
  • 190
  • 191
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley